Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories at midday » 12:25
03/02/21
03/02
12:25
03/02/21
12:25
TGT

Target

$177.29 /

-8.83 (-4.74%)

, KSS

Kohl's

$58.35 /

+1.4 (+2.46%)

, JNJ

Johnson & Johnson

$159.38 /

+0.05 (+0.03%)

, MRK

Merck

$73.20 /

+0.83 (+1.15%)

, ZM

Zoom Video

$401.54 /

-8.125 (-1.98%)

, PERI

Perion Network

$27.00 /

+5.495 (+25.55%)

, AMRS

Amyris

$20.46 /

+4.84 (+30.99%)

, MORF

Morphic

$73.25 /

-11.56 (-13.63%)

, FGEN

FibroGen

$35.50 /

-14.76 (-29.37%)

, NVAX

Novavax

$201.33 /

-39 (-16.23%)

Equity futures were…

ShowHide Related Items >><<
ZM Zoom Video
$401.54 /

-8.125 (-1.98%)

TGT Target
$177.29 /

-8.83 (-4.74%)

PERI Perion Network
$27.00 /

+5.495 (+25.55%)

NVAX Novavax
$201.33 /

-39 (-16.23%)

MRK Merck
$73.20 /

+0.83 (+1.15%)

MORF Morphic
$73.25 /

-11.56 (-13.63%)

KSS Kohl's
$58.35 /

+1.4 (+2.46%)

JNJ Johnson & Johnson
$159.38 /

+0.05 (+0.03%)

FGEN FibroGen
$35.50 /

-14.76 (-29.37%)

AMRS Amyris
$20.46 /

+4.84 (+30.99%)

TGT Target
$177.29 /

-8.83 (-4.74%)

02/09/21 Jefferies
Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Stifel
Target upgraded to Buy from Hold at Stifel
01/14/21 DA Davidson
Target price target raised to $229 from $208 at DA Davidson
KSS Kohl's
$58.35 /

+1.4 (+2.46%)

02/18/21 Morgan Stanley
Kohl's price target raised to $40 from $27 at Morgan Stanley
02/05/21 Baird
Kohl's price target raised to $58 from $48 at Baird
02/05/21 Deutsche Bank
Kohl's price target raised to $55 from $51 at Deutsche Bank
02/03/21
Fly Intel: Top five analyst upgrades
JNJ Johnson & Johnson
$159.38 /

+0.05 (+0.03%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MRK Merck
$73.20 /

+0.83 (+1.15%)

02/25/21 SVB Leerink
Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
02/25/21 Morgan Stanley
Pandion downgraded to Equal Weight from Overweight at Morgan Stanley
02/17/21 William Blair
William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ
01/21/21 Wedbush
Scholar Rock price target raised to $66 from $47 at Wedbush
ZM Zoom Video
$401.54 /

-8.125 (-1.98%)

09:56 Today
Fly Intel: Top five analyst upgrades
07:15 Today Morgan Stanley
Zoom Video price target raised to $420 from $390 at Morgan Stanley
06:07 Today Piper Sandler
Zoom Video upgraded to Overweight from Neutral at Piper Sandler
01/26/21 MKM Partners
Fiverr downgraded to Sell from Neutral at MKM Partners
PERI Perion Network
$27.00 /

+5.495 (+25.55%)

02/10/21 Lake Street
Perion Network price target raised to $30 from $18 at Lake Street
02/10/21 Roth Capital
Perion Network price target raised to $30 from $16 at Roth Capital
01/04/21 Lake Street
Perion Network price target raised to $18 from $12 at Lake Street
12/31/20 Sidoti
Perion Network price target raised to $14 from $12 at Sidoti
AMRS Amyris
$20.46 /

+4.84 (+30.99%)

02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Roth Capital
Amyris initiated with a Buy at Roth Capital
01/06/21 Cowen
Amyris upgraded to Outperform with $9 price target at Cowen
01/06/21 Cowen
Amyris upgraded to Outperform from Market Perform at Cowen
MORF Morphic
$73.25 /

-11.56 (-13.63%)

03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
FGEN FibroGen
$35.50 /

-14.76 (-29.37%)

09:56 Today
Fly Intel: Top five analyst downgrades
08:21 Today Jefferies
FibroGen downgraded to Hold at Jefferies on increased risk for roxadustat
06:24 Today Citi
FibroGen selloff on FDA panel a buying opportunity, says Citi
04:47 Today Jefferies
FibroGen downgraded to Hold from Buy at Jefferies
NVAX Novavax
$201.33 /

-39 (-16.23%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/22/21 Cantor Fitzgerald
Cantor says PREVENT-19 gives Novavax potential for differentiated analyses
02/22/21 B. Riley Securities
B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up
02/18/21 B. Riley Securities
Novavax price target raised to $397 from $334 at B. Riley Securities
ZM Zoom Video
$401.54 /

-8.125 (-1.98%)

TGT Target
$177.29 /

-8.83 (-4.74%)

PERI Perion Network
$27.00 /

+5.495 (+25.55%)

NVAX Novavax
$201.33 /

-39 (-16.23%)

MRK Merck
$73.20 /

+0.83 (+1.15%)

MORF Morphic
$73.25 /

-11.56 (-13.63%)

KSS Kohl's
$58.35 /

+1.4 (+2.46%)

JNJ Johnson & Johnson
$159.38 /

+0.05 (+0.03%)

FGEN FibroGen
$35.50 /

-14.76 (-29.37%)

AMRS Amyris
$20.46 /

+4.84 (+30.99%)

  • 03
    Mar
  • 20
    Jan
  • 13
    Jan
ZM Zoom Video
$401.54 /

-8.125 (-1.98%)

TGT Target
$177.29 /

-8.83 (-4.74%)

NVAX Novavax
$201.33 /

-39 (-16.23%)

MRK Merck
$73.20 /

+0.83 (+1.15%)

KSS Kohl's
$58.35 /

+1.4 (+2.46%)

JNJ Johnson & Johnson
$159.38 /

+0.05 (+0.03%)

ZM Zoom Video
$401.54 /

-8.125 (-1.98%)

TGT Target
$177.29 /

-8.83 (-4.74%)

PERI Perion Network
$27.00 /

+5.495 (+25.55%)

NVAX Novavax
$201.33 /

-39 (-16.23%)

MRK Merck
$73.20 /

+0.83 (+1.15%)

KSS Kohl's
$58.35 /

+1.4 (+2.46%)

JNJ Johnson & Johnson
$159.38 /

+0.05 (+0.03%)

FGEN FibroGen
$35.50 /

-14.76 (-29.37%)

AMRS Amyris
$20.46 /

+4.84 (+30.99%)

ZM Zoom Video
$401.54 /

-8.125 (-1.98%)

TGT Target
$177.29 /

-8.83 (-4.74%)

NVAX Novavax
$201.33 /

-39 (-16.23%)

MRK Merck
$73.20 /

+0.83 (+1.15%)

KSS Kohl's
$58.35 /

+1.4 (+2.46%)

JNJ Johnson & Johnson
$159.38 /

+0.05 (+0.03%)

FGEN FibroGen
$35.50 /

-14.76 (-29.37%)

AMRS Amyris
$20.46 /

+4.84 (+30.99%)

Hot Stocks
Capri Holdings appoints Alejandro Martinez-Galindo as CIO » 11:04
03/02/21
03/02
11:04
03/02/21
11:04
CPRI

Capri Holdings

$47.97 /

-0.26 (-0.54%)

, WBA

Walgreens Boots Alliance

$47.45 /

-0.42 (-0.88%)

Capri Holdings (CPRI)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$47.45 /

-0.42 (-0.88%)

CPRI Capri Holdings
$47.97 /

-0.26 (-0.54%)

CPRI Capri Holdings
$47.97 /

-0.26 (-0.54%)

02/04/21
Capri Holdings price target raised to $52 from $50 at Barclays
01/29/21 Baird
Capri upgraded to Outperform on multi-year recovery at Baird
01/29/21 Baird
Capri Holdings upgraded to Outperform from Neutral at Baird
01/27/21 Citi
Capri Holdings price target raised to $53 from $32 at Citi
WBA Walgreens Boots Alliance
$47.45 /

-0.42 (-0.88%)

01/27/21 Deutsche Bank
Walgreens Boots Alliance price target raised to $49 from $44 at Deutsche Bank
01/15/21 Baird
Walgreens Boots Alliance price target raised to $64 from $55 at Baird
01/11/21
Fly Intel: Top five analyst upgrades
01/11/21 Baird
Baird upgrades Walgreens Boots Alliance following Q1 results
WBA Walgreens Boots Alliance
$47.45 /

-0.42 (-0.88%)

CPRI Capri Holdings
$47.97 /

-0.26 (-0.54%)

WBA Walgreens Boots Alliance
$47.45 /

-0.42 (-0.88%)

CPRI Capri Holdings
$47.97 /

-0.26 (-0.54%)

WBA Walgreens Boots Alliance
$47.45 /

-0.42 (-0.88%)

CPRI Capri Holdings
$47.97 /

-0.26 (-0.54%)

WBA Walgreens Boots Alliance
$47.45 /

-0.42 (-0.88%)

CPRI Capri Holdings
$47.97 /

-0.26 (-0.54%)

Conference/Events
Credit Suisse to hold a virtual conference » 09:17
03/02/21
03/02
09:17
03/02/21
09:17
ABC

AmerisourceBergen

$103.12 /

+1.88 (+1.86%)

, AFMD

Affimed N.V.

$5.91 /

+0.25 (+4.42%)

, AMED

Amedisys

$254.74 /

+0.61 (+0.24%)

, AZN

AstraZeneca

$48.10 /

-0.25 (-0.52%)

, BNTX

BioNTech

$110.06 /

+0.61 (+0.56%)

, CSL

Carlisle

$148.03 /

+2.725 (+1.88%)

, CVAC

CureVac

$96.15 /

+1.39 (+1.47%)

, FMS

Fresenius Medical

$35.05 /

+0.49 (+1.42%)

, GLPG

Galapagos

$84.65 /

+1.6 (+1.93%)

, GLTO

Galecto

$10.81 /

+0.5301 (+5.16%)

, GSK

GlaxoSmithKline

$33.74 /

+0.13 (+0.39%)

, IVA

Inventiva

$16.90 /

+1.9 (+12.67%)

, IPSEY

Ipsen

$0.00 /

+ (+0.00%)

, LNTH

Lantheus

$19.06 /

+0.33 (+1.76%)

, NOV

NOV Inc.

$15.65 /

+0.525 (+3.47%)

, NOVO

Novo Group Inc

$0.00 /

+ (+0.00%)

, NVS

Novartis

$87.44 /

+1.42 (+1.65%)

, PHG

Philips

$55.04 /

+0.54 (+0.99%)

, SNY

Sanofi

$45.90 /

+0.015 (+0.03%)

, TAK

Takeda Pharmaceutical

$16.97 /

+0.26 (+1.56%)

, ZEAL

Zealand Pharma

$32.71 /

+0.76 (+2.38%)

2021 London Global…

2021 London Global Healthcare Virtual Conference will be held on March 2-4. Webcast Link

ShowHide Related Items >><<
ZEAL Zealand Pharma
$32.71 /

+0.76 (+2.38%)

TAK Takeda Pharmaceutical
$16.97 /

+0.26 (+1.56%)

SNY Sanofi
$45.90 /

+0.015 (+0.03%)

PHG Philips
$55.04 /

+0.54 (+0.99%)

NVS Novartis
$87.44 /

+1.42 (+1.65%)

NOV NOV Inc.
$15.65 /

+0.525 (+3.47%)

LNTH Lantheus
$19.06 /

+0.33 (+1.76%)

IVA Inventiva
$16.90 /

+1.9 (+12.67%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$33.74 /

+0.13 (+0.39%)

GLTO Galecto
$10.81 /

+0.5301 (+5.16%)

GLPG Galapagos
$84.65 /

+1.6 (+1.93%)

FMS Fresenius Medical
$35.05 /

+0.49 (+1.42%)

CVAC CureVac
$96.15 /

+1.39 (+1.47%)

CSL Carlisle
$148.03 /

+2.725 (+1.88%)

BNTX BioNTech
$110.06 /

+0.61 (+0.56%)

AZN AstraZeneca
$48.10 /

-0.25 (-0.52%)

AMED Amedisys
$254.74 /

+0.61 (+0.24%)

AFMD Affimed N.V.
$5.91 /

+0.25 (+4.42%)

ABC AmerisourceBergen
$103.12 /

+1.88 (+1.86%)

ABC AmerisourceBergen
$103.12 /

+1.88 (+1.86%)

02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform from In Line at Evercore ISI
AFMD Affimed N.V.
$5.91 /

+0.25 (+4.42%)

AMED Amedisys
$254.74 /

+0.61 (+0.24%)

02/23/21 Benchmark
Amedisys price target raised to $325 from $275 at Benchmark
02/08/21 Deutsche Bank
Amedisys price target raised to $340 from $275 at Deutsche Bank
01/05/21 Truist
Amedisys price target raised to $325 from $280 at Truist
11/03/20 Barclays
Amedisys price target raised to $298 from $290 at Barclays
AZN AstraZeneca
$48.10 /

-0.25 (-0.52%)

02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 UBS
AstraZeneca upgraded to Buy from Neutral at UBS
02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
BNTX BioNTech
$110.06 /

+0.61 (+0.56%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
CSL Carlisle
$148.03 /

+2.725 (+1.88%)

01/26/21 Longbow
Carlisle price target raised to $160 from $150 at Longbow
01/08/21 Oppenheimer
Carlisle price target raised to $175 from $160 at Oppenheimer
11/13/20
Carlisle cut to Hold at Loop Capital on valuation
11/13/20 Loop Capital
Carlisle downgraded to Hold from Buy at Loop Capital
CVAC CureVac
$96.15 /

+1.39 (+1.47%)

01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
12/10/20 Credit Suisse
CureVac downgraded to Underperform from Neutral at Credit Suisse
11/02/20 Piper Sandler
CureVac's positive vaccine data bodes well for Arcturus's ARCT-021, says Piper
FMS Fresenius Medical
$35.05 /

+0.49 (+1.42%)

02/26/21 JPMorgan
Fresenius Medical price target raised to EUR 52.40 from EUR 51.10 at JPMorgan
02/24/21 Truist
Fresenius Medical cut to Hold at Truist on more difficult operating backdrop
02/24/21 Truist
Fresenius Medical downgraded to Hold from Buy at Truist
02/17/21 UBS
Fresenius Medical price target lowered to EUR 72 from EUR 94 at UBS
GLPG Galapagos
$84.65 /

+1.6 (+1.93%)

02/23/21 BofA
Galapagos upgraded to Neutral from Underperform at BofA
02/23/21 BofA
Galapagos upgraded to Neutral from Underperform at BofA
02/19/21 Raymond James
Raymond James upgrades 'heavily discounted' Galapagos to Outperform
02/19/21 Raymond James
Galapagos upgraded to Outperform from Market Perform at Raymond James
GLTO Galecto
$10.81 /

+0.5301 (+5.16%)

11/23/20 SVB Leerink
SVB Leerink bullish on Galecto, initiates with an Outperform
11/23/20 SVB Leerink
Galecto initiated with an Outperform at SVB Leerink
11/23/20 Credit Suisse
Galecto initiated with an Outperform at Credit Suisse
11/23/20 BofA
Galecto initiated with a Buy at BofA
GSK GlaxoSmithKline
$33.74 /

+0.13 (+0.39%)

02/12/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,580 GBp at Morgan Stanley
02/11/21 Berenberg
GlaxoSmithKline price target lowered to 1,570 GBp from 1,720 GBp at Berenberg
02/09/21 JPMorgan
GlaxoSmithKline price target lowered to 1,300 GBp from 1,500 GBp at JPMorgan
02/08/21 UBS
GlaxoSmithKline price target lowered to 1,320 GBp from 1,450 GBp at UBS
IVA Inventiva
$16.90 /

+1.9 (+12.67%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
IPSEY Ipsen
$0.00 /

+ (+0.00%)

02/16/21 Barclays
Ipsen price target lowered to EUR 89 from EUR 96 at Barclays
01/14/21 Societe Generale
Ipsen upgraded to Buy from Hold at Societe Generale
12/08/20 Morgan Stanley
Ipsen downgraded to Equal Weight from Overweight at Morgan Stanley
12/04/20 BofA
Ipsen downgraded to Neutral from Buy at BofA
LNTH Lantheus
$19.06 /

+0.33 (+1.76%)

02/01/21
Fly Intel: Top five analyst initiations
02/01/21 SVB Leerink
SVB Leerink bullish on Lantheus, initiates with an Outperform
02/01/21 SVB Leerink
Lantheus initiated with an Outperform at SVB Leerink
12/29/20 Credit Suisse
Lantheus price target lowered to $14 from $16 at Credit Suisse
NOV NOV Inc.
$15.65 /

+0.525 (+3.47%)

01/21/21 Susquehanna
NOV Inc. price target lowered to $17 from $18 at Susquehanna
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/12/21 Citi
NOV Inc. upgraded to Buy from Neutral at Citi
NOVO Novo Group Inc
$0.00 /

+ (+0.00%)

NVS Novartis
$87.44 /

+1.42 (+1.65%)

03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
02/02/21 Morgan Stanley
Novartis price target lowered to CHF 102 from CHF 104 at Morgan Stanley
02/01/21 Truist
iRhythm price target lowered to $220 from $265 at Truist
02/01/21 Cowen
Novartis downgraded to Market Perform after 'tepid' guidance at Cowen
PHG Philips
$55.04 /

+0.54 (+0.99%)

01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
SNY Sanofi
$45.90 /

+0.015 (+0.03%)

02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
01/19/21 UBS
Sanofi price target lowered to EUR 99 from EUR 100 at UBS
TAK Takeda Pharmaceutical
$16.97 /

+0.26 (+1.56%)

01/29/21 Morgan Stanley
Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout
12/29/20 Needham
Needham names Phathom Pharmaceuticals Top Pick for 2021
12/15/20 Needham
Phathom Pharmaceuticals price target raised to $55 from $45 at Needham
06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
ZEAL Zealand Pharma
$32.71 /

+0.76 (+2.38%)

03/10/20 Morgan Stanley
Zealand Pharma EPS estimates cut at Morgan Stanley
ZEAL Zealand Pharma
$32.71 /

+0.76 (+2.38%)

SNY Sanofi
$45.90 /

+0.015 (+0.03%)

PHG Philips
$55.04 /

+0.54 (+0.99%)

NVS Novartis
$87.44 /

+1.42 (+1.65%)

NOV NOV Inc.
$15.65 /

+0.525 (+3.47%)

LNTH Lantheus
$19.06 /

+0.33 (+1.76%)

GSK GlaxoSmithKline
$33.74 /

+0.13 (+0.39%)

GLTO Galecto
$10.81 /

+0.5301 (+5.16%)

GLPG Galapagos
$84.65 /

+1.6 (+1.93%)

CSL Carlisle
$148.03 /

+2.725 (+1.88%)

AZN AstraZeneca
$48.10 /

-0.25 (-0.52%)

AMED Amedisys
$254.74 /

+0.61 (+0.24%)

ABC AmerisourceBergen
$103.12 /

+1.88 (+1.86%)

  • 28
    Jan
  • 13
    Jan
  • 29
    Oct
  • 14
    Aug
  • 23
    Jul
  • 10
    Jul
TAK Takeda Pharmaceutical
$16.97 /

+0.26 (+1.56%)

SNY Sanofi
$45.90 /

+0.015 (+0.03%)

PHG Philips
$55.04 /

+0.54 (+0.99%)

NVS Novartis
$87.44 /

+1.42 (+1.65%)

GSK GlaxoSmithKline
$33.74 /

+0.13 (+0.39%)

FMS Fresenius Medical
$35.05 /

+0.49 (+1.42%)

CVAC CureVac
$96.15 /

+1.39 (+1.47%)

BNTX BioNTech
$110.06 /

+0.61 (+0.56%)

AZN AstraZeneca
$48.10 /

-0.25 (-0.52%)

ABC AmerisourceBergen
$103.12 /

+1.88 (+1.86%)

SNY Sanofi
$45.90 /

+0.015 (+0.03%)

PHG Philips
$55.04 /

+0.54 (+0.99%)

NVS Novartis
$87.44 /

+1.42 (+1.65%)

NOV NOV Inc.
$15.65 /

+0.525 (+3.47%)

LNTH Lantheus
$19.06 /

+0.33 (+1.76%)

IVA Inventiva
$16.90 /

+1.9 (+12.67%)

GSK GlaxoSmithKline
$33.74 /

+0.13 (+0.39%)

GLTO Galecto
$10.81 /

+0.5301 (+5.16%)

GLPG Galapagos
$84.65 /

+1.6 (+1.93%)

CVAC CureVac
$96.15 /

+1.39 (+1.47%)

BNTX BioNTech
$110.06 /

+0.61 (+0.56%)

AZN AstraZeneca
$48.10 /

-0.25 (-0.52%)

AMED Amedisys
$254.74 /

+0.61 (+0.24%)

ABC AmerisourceBergen
$103.12 /

+1.88 (+1.86%)

TAK Takeda Pharmaceutical
$16.97 /

+0.26 (+1.56%)

NOV NOV Inc.
$15.65 /

+0.525 (+3.47%)

GSK GlaxoSmithKline
$33.74 /

+0.13 (+0.39%)

CVAC CureVac
$96.15 /

+1.39 (+1.47%)

BNTX BioNTech
$110.06 /

+0.61 (+0.56%)

AZN AstraZeneca
$48.10 /

-0.25 (-0.52%)

ABC AmerisourceBergen
$103.12 /

+1.88 (+1.86%)

Periodicals
Merck to help produce J&J Covid vaccine, Washington Post reports » 08:03
03/02/21
03/02
08:03
03/02/21
08:03
MRK

Merck

$72.37 /

-0.28 (-0.39%)

, JNJ

Johnson & Johnson

$159.34 /

+0.92 (+0.58%)

President Biden will…

President Biden will announce today that Merck (MRK) will help make Johnson & Johnson's (JNJ) single-shot coronavirus vaccine, Laurie McGinley and Christopher Rowland of Washington Post report, citing senior administration officials. Under the arrangement, Merck will dedicate two facilities in the United States to Johnson & Johnson's shots, officials told the paper. Reference Link

ShowHide Related Items >><<
MRK Merck
$72.37 /

-0.28 (-0.39%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

MRK Merck
$72.37 /

-0.28 (-0.39%)

02/25/21 SVB Leerink
Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
02/25/21 Morgan Stanley
Pandion downgraded to Equal Weight from Overweight at Morgan Stanley
02/17/21 William Blair
William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ
01/21/21 Wedbush
Scholar Rock price target raised to $66 from $47 at Wedbush
JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MRK Merck
$72.37 /

-0.28 (-0.39%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

MRK Merck
$72.37 /

-0.28 (-0.39%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

MRK Merck
$72.37 /

-0.28 (-0.39%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

MRK Merck
$72.37 /

-0.28 (-0.39%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

Recommendations
McKesson price target raised to $224 from $210 at Cowen » 07:41
03/02/21
03/02
07:41
03/02/21
07:41
MCK

McKesson

$173.75 /

+4.94 (+2.93%)

Cowen analyst Charles…

Cowen analyst Charles Ryhee raised the firm's price target on McKesson to $224 from $210 and keeps an Outperform rating on the shares. The analyst raised his target as he is incrementally positive on the company given its suite of differentiated assets in oncology biopharma services an med-surg which are expected to be key growth drivers going forward.

ShowHide Related Items >><<
MCK McKesson
$173.75 /

+4.94 (+2.93%)

MCK McKesson
$173.75 /

+4.94 (+2.93%)

02/03/21 Credit Suisse
McKesson price target raised to $192 from $178 at Credit Suisse
02/03/21 Deutsche Bank
McKesson price target raised to $231 from $222 at Deutsche Bank
02/03/21 Mizuho
McKesson price target raised to $190 from $178 at Mizuho
02/01/21 Cowen
McKesson price target raised to $210 from $186 at Cowen
MCK McKesson
$173.75 /

+4.94 (+2.93%)

MCK McKesson
$173.75 /

+4.94 (+2.93%)

MCK McKesson
$173.75 /

+4.94 (+2.93%)

MCK McKesson
$173.75 /

+4.94 (+2.93%)

Downgrade
Cowen downgrades Ontrak to Market Perform until visibility returns » 07:39
03/02/21
03/02
07:39
03/02/21
07:39
OTRK

Ontrak

$31.62 /

-27.515 (-46.53%)

, CVS

CVS Health

$69.26 /

+1.13 (+1.66%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

07:28 Today Canaccord
Canaccord downgrades Ontrak after loss of largest customer
05:57 Today Cowen
Ontrak downgraded to Market Perform from Outperform at Cowen
05:37 Today Canaccord
Ontrak downgraded to Hold from Buy at Canaccord
03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
CVS CVS Health
$69.26 /

+1.13 (+1.66%)

01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
01/22/21 Baird
Tabula Rasa HealthCare may have lost MTM deal at Aetna, says Baird
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

Downgrade
Canaccord downgrades Ontrak after loss of largest customer » 07:28
03/02/21
03/02
07:28
03/02/21
07:28
OTRK

Ontrak

$31.62 /

-27.515 (-46.53%)

, CVS

CVS Health

$69.26 /

+1.13 (+1.66%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

05:57 Today Cowen
Ontrak downgraded to Market Perform from Outperform at Cowen
05:37 Today Canaccord
Ontrak downgraded to Hold from Buy at Canaccord
03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
03/01/21 RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
CVS CVS Health
$69.26 /

+1.13 (+1.66%)

01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
01/22/21 Baird
Tabula Rasa HealthCare may have lost MTM deal at Aetna, says Baird
01/19/21 JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

CVS CVS Health
$69.26 /

+1.13 (+1.66%)

Periodicals
Johnson & Johnson Covid-19 vaccine shipments begin rollout, WSJ reports » 06:20
03/02/21
03/02
06:20
03/02/21
06:20
JNJ

Johnson & Johnson

$159.34 /

+0.92 (+0.58%)

, MCK

McKesson

$173.75 /

+4.94 (+2.93%)

, FDX

FedEx

$262.13 /

+7.1 (+2.78%)

, UPS

UPS

$161.44 /

+3.52 (+2.23%)

Trucks carrying Johnson…

Trucks carrying Johnson & Johnson's (JNJ) newly authorized Covid-19 vaccine started rolling out Monday en route to states and sites that have been seeking additional doses to boost vaccinations, The Wall Street Journal's Peter Loftus and Ken Thomas report. McKesson (MCK), which is serving as the centralized distributor for J&J vaccines, is working with FedEx (FDX) and UPS (UPS) to ship the doses nationwide. The shipments are expected to reach states and vaccination sites as early as Tuesday, the Biden administration said. Reference Link

ShowHide Related Items >><<
UPS UPS
$161.44 /

+3.52 (+2.23%)

MCK McKesson
$173.75 /

+4.94 (+2.93%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

FDX FedEx
$262.13 /

+7.1 (+2.78%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MCK McKesson
$173.75 /

+4.94 (+2.93%)

02/03/21 Credit Suisse
McKesson price target raised to $192 from $178 at Credit Suisse
02/03/21 Deutsche Bank
McKesson price target raised to $231 from $222 at Deutsche Bank
02/03/21 Mizuho
McKesson price target raised to $190 from $178 at Mizuho
02/01/21 Cowen
McKesson price target raised to $210 from $186 at Cowen
FDX FedEx
$262.13 /

+7.1 (+2.78%)

01/07/21 Wolfe Research
FedEx downgraded to Peer Perform from Outperform at Wolfe Research
12/30/20 Argus
FedEx price target raised to $305 from $270 at Argus
12/18/20 Raymond James
FedEx price target raised to $305 from $280 at Raymond James
12/18/20 Morgan Stanley
FedEx's 'modest' Q2 beat likely falls short of high bar, says Morgan Stanley
UPS UPS
$161.44 /

+3.52 (+2.23%)

02/12/21 UBS
TFI International downgraded to Neutral from Buy at UBS
02/08/21 Craig-Hallum
Clean Energy price target raised to $25 from $12 at Craig-Hallum
02/08/21 Craig-Hallum
Westport target raised to $24 following Amazon truck order, says Craig-Hallum
02/04/21 Deutsche Bank
UPS price target lowered to $185 from $201 at Deutsche Bank
UPS UPS
$161.44 /

+3.52 (+2.23%)

MCK McKesson
$173.75 /

+4.94 (+2.93%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

FDX FedEx
$262.13 /

+7.1 (+2.78%)

UPS UPS
$161.44 /

+3.52 (+2.23%)

MCK McKesson
$173.75 /

+4.94 (+2.93%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

FDX FedEx
$262.13 /

+7.1 (+2.78%)

UPS UPS
$161.44 /

+3.52 (+2.23%)

MCK McKesson
$173.75 /

+4.94 (+2.93%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

FDX FedEx
$262.13 /

+7.1 (+2.78%)

UPS UPS
$161.44 /

+3.52 (+2.23%)

MCK McKesson
$173.75 /

+4.94 (+2.93%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

FDX FedEx
$262.13 /

+7.1 (+2.78%)

Yesterday
On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:45
03/01/21
03/01
16:45
03/01/21
16:45
JNJ

Johnson & Johnson

$159.34 /

+0.92 (+0.58%)

, XOM

Exxon Mobil

$56.40 /

+2.02 (+3.71%)

, OTRK

Ontrak

$31.62 /

-27.515 (-46.53%)

, ATNX

Athenex

$5.47 /

-6.715 (-55.11%)

, DKNG

DraftKings

$68.71 /

+7.24 (+11.78%)

, MORF

Morphic

$84.57 /

+48.64 (+135.37%)

The three major averages…

ShowHide Related Items >><<
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

07:00 Today Wells Fargo
Exxon Mobil price target raised to $65 from $53 at Wells Fargo
02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

08:36 Today B. Riley Securities
Ontrak price target lowered to $73 from $110 at B. Riley Securities
07:39 Today Cowen
Cowen downgrades Ontrak to Market Perform until visibility returns
07:28 Today Canaccord
Canaccord downgrades Ontrak after loss of largest customer
05:57 Today Cowen
Ontrak downgraded to Market Perform from Outperform at Cowen
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

08:31 Today SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
07:27 Today Oppenheimer
Athenex downgraded to Perform from Outperform at Oppenheimer
07:13 Today Truist
Athenex downgraded to Hold from Buy at Truist
06:39 Today RBC Capital
Athenex price target lowered to $9 from $33 at RBC Capital
DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

03/01/21 Craig-Hallum
DraftKings price target raised to $70 from $65 at Craig-Hallum
03/01/21 Canaccord
DraftKings price target raised to $80 from $65 at Canaccord
03/01/21 Northland
DraftKings price target raised to $70 from $55 at Northland
03/01/21 Benchmark
DraftKings price target raised to $69 from $66 at Benchmark
MORF Morphic
$84.57 /

+48.64 (+135.37%)

03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

  • 07
    Oct
  • 10
    Sep
  • 19
    Jun
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

Conference/Events
Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 15:48
03/01/21
03/01
15:48
03/01/21
15:48
ADVM

Adverum Biotechnologies

$13.31 /

+0.455 (+3.54%)

, UBX

Unity Biotechnology

$7.53 /

+0.7 (+10.25%)

, AGTC

Applied Genetic

$5.64 /

+0.54 (+10.59%)

, JNJ

Johnson & Johnson

$159.50 /

+1.08 (+0.68%)

, MGTX

MeiraGTx

$15.21 /

+0.4 (+2.70%)

, NITE

Nightstar Therapeutics

$25.41 /

+ (+0.00%)

, BIIB

Biogen

$272.79 /

-0.16 (-0.06%)

, AERI

Aerie Pharmaceuticals

$19.36 /

+0.96 (+5.22%)

, ALDX

Aldeyra

$12.20 /

-0.05 (-0.41%)

Biopharmaceuticals…

Biopharmaceuticals Analyst Chen, along with Dr. Ruchita Amin, Retina Specialist at Retina Vitreous Associates and Dr. Roger Goldberg, Partner and Vitreoretinal Surgeon at Bay Area Retina Associates, discuss hot topics and key 2021 focus areas in eye diseases on an Analyst/Industry Conference Call to be held on March 8 at 1 pm.

ShowHide Related Items >><<
UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

MGTX MeiraGTx
$15.21 /

+0.4 (+2.70%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

ADVM Adverum Biotechnologies
$13.31 /

+0.455 (+3.54%)

ADVM Adverum Biotechnologies
$13.31 /

+0.455 (+3.54%)

12/15/20 UBS
Adverum Biotechnologies initiated with a Neutral at UBS
11/15/20 Piper Sandler
Adverum Biotechnologies shares should grind higher over time, says Piper Sandler
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform at Raymond James
UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

02/16/21 Citi
Unity Biotechnology downgraded to Sell from Neutral at Citi
08/18/20
Fly Intel: Top five analyst downgrades
08/18/20 Morgan Stanley
Unity Biotechnology downgraded at Morgan Stanley as UBX101 doesn't meet endpoint
08/18/20 Citi
Unity Biotechnology downgraded to Neutral from Buy at Citi
AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
11/11/20 H.C. Wainwright
Applied Genetic XLRP data 'continue to impress,' says H.C. Wainwright
JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MGTX MeiraGTx
$15.21 /

+0.4 (+2.70%)

02/16/21 Chardan
MeiraGTx called a Top Pick for 2021 at Chardan
12/17/20 Chardan
Chardan boosts MeiraGTx target to $55, say buy shares 'now'
12/17/20 Piper Sandler
Piper says MeiraGTx not getting credit for RIX gene therapy that 'clearly works'
10/22/20 RBC Capital
MeiraGTx initiated with an Outperform at RBC Capital
NITE Nightstar Therapeutics
$25.41 /

+ (+0.00%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
02/08/21 Citi
Expert sees Biogen aducanumab approval 50/50 at best, says Citi
02/04/21 SVB Leerink
Biogen price target lowered to $380 from $430 at SVB Leerink
02/04/21 Credit Suisse
Biogen price target lowered to $338 from $350 at Credit Suisse
AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

11/09/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright
10/28/20 H.C. Wainwright
Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

02/08/21 H.C. Wainwright
Aldeyra initiated with a Buy at H.C. Wainwright
01/28/21 JonesTrading
Aldeyra assumed with a Buy at JonesTrading
01/08/21 Jefferies
Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies
01/08/21 Citi
Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi
UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

MGTX MeiraGTx
$15.21 /

+0.4 (+2.70%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

ADVM Adverum Biotechnologies
$13.31 /

+0.455 (+3.54%)

  • 28
    Jan
  • 14
    Jan
  • 19
    Nov
  • 13
    Aug
JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.